PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Abroad (travel likely)Recruiting

Conditions

Acute Coronary Syndrome · Hyperlipidemias · Percutaneous Coronary Intervention · Cardiovascular Events

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nanjing First Hospital, Nanjing, Jiangsu, China
Contact: Study coordinator (Shaoliang Chen, MD) · chmengx@126.com · +86 13605157029

Study leads

Shao-Liang Chen, MD, PhD
Study Chair
Nanjing First Hospital, Nanjing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Coronary Artery Disease · Percutaneous Coronary Intervention · Acute Coronary Syndrome

Abroad (travel likely)RecruitingPHASE4

Anyang, South Korea · Bucheon-si, South Korea

CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

Coronary · Coronary Artery Disease

Abroad (travel likely)RecruitingPHASE4

Chengdu, China

Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).

Coronary Arterial Disease (CAD) · Coronary Calcification · Coronary Calcified Nodules

Abroad (travel likely)Recruiting

Alicante, Spain · Lugo, Spain

Naples PCI Registry

Coronary Artery Disease · Percutaneous Coronary Intervention · Myocardial Ischemia

Abroad (travel likely)Recruiting

Naples, Italy